AI-generated summary
This review describes lasers and light-based devices used for melasma, a chronic pigmentary condition, including photobiomodulation, Q-switched Nd:YAG, picosecond and fractional lasers. The authors report that these modalities have shown promising results, but that no single one offers a definitive solution. They note that combination therapies yield better results, maintenance treatment helps prevent recurrence, and laser treatment carries risks such as postinflammatory hyperpigmentation, especially in darker skin types.
- Who or what was studied
- Patients with melasma
- Limits stated in the abstract
- The abstract does not report the number of studies or patients reviewed, and states that no single modality offers a definitive solution.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Photobiomodulation, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.